In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy.
circulating tumor cells
in vivo detection
non-metastatic prostate cancer
radiotherapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
03 Jul 2019
03 Jul 2019
Historique:
received:
12
05
2019
revised:
20
06
2019
accepted:
28
06
2019
entrez:
7
7
2019
pubmed:
7
7
2019
medline:
7
7
2019
Statut:
epublish
Résumé
High-risk non-metastatic prostate cancer (PCa) has the potential to progress into lethal disease. Treatment options are manifold but, given a lack of surrogate biomarkers, it remains unclear which treatment offers the best results. Several studies have reported circulating tumor cells (CTCs) to be a prognostic biomarker in metastatic PCa. However, few reports on CTCs in high-risk non-metastatic PCa are available. Herein, we evaluated CTC detection in high-risk non-metastatic PCa patients using the in vivo CellCollector CANCER01 (DC01) and CellSearch system. CTC counts were analyzed and compared before and after radiotherapy (two sampling time points) in 51 high-risk non-metastatic PCa patients and were further compared according to isolation technique; further, CTC counts were correlated to clinical features. Use of DC01 resulted in a significantly higher percentage of CTC-positive samples compared to CellSearch (33.7% vs. 18.6%;
Identifiants
pubmed: 31277254
pii: cancers11070933
doi: 10.3390/cancers11070933
pmc: PMC6678903
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Austrian Science Fund (FWF)
ID : I 1220-B19
Organisme : Franz Lanyar-Stiftung at the Medical University Graz
ID : #394
Références
Cancer Cell. 2003 Sep;4(3):209-21
pubmed: 14522255
N Engl J Med. 2004 Aug 19;351(8):781-91
pubmed: 15317891
Cancer Res. 2004 Dec 15;64(24):9209-16
pubmed: 15604294
Oncogene. 2005 May 26;24(23):3847-52
pubmed: 15750627
Urology. 2005 Apr;65(4):713-8
pubmed: 15833514
Science. 2005 Oct 28;310(5748):644-8
pubmed: 16254181
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):965-74
pubmed: 16798415
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4218-24
pubmed: 16857794
Cancer Res. 2006 Sep 1;66(17):8337-41
pubmed: 16951139
J Urol. 2007 Feb;177(2):540-5
pubmed: 17222629
Clin Cancer Res. 2007 Feb 1;13(3):920-8
pubmed: 17289886
Clin Cancer Res. 2007 Jul 15;13(14):4105-10
pubmed: 17634536
Urology. 2007 Oct;70(4):630-3
pubmed: 17991527
Clin Cancer Res. 2007 Dec 1;13(23):7053-8
pubmed: 18056182
Cancer Cell. 2008 Jan;13(1):58-68
pubmed: 18167340
J Urol. 2008 Jun;179(6):2187-91; discussion 2191
pubmed: 18423725
Clin Cancer Res. 2008 Oct 1;14(19):6302-9
pubmed: 18829513
Cancer Res. 2009 Mar 15;69(6):2305-13
pubmed: 19244107
J Clin Oncol. 2009 May 1;27(13):2177-84
pubmed: 19332733
Nat Rev Clin Oncol. 2009 Jun;6(6):339-51
pubmed: 19399023
Ann Oncol. 2010 Apr;21(4):729-33
pubmed: 19850639
Ann Oncol. 2010 May;21(5):1006-12
pubmed: 19861577
J Clin Invest. 2010 Aug;120(8):2715-30
pubmed: 20644256
Ann N Y Acad Sci. 2010 Oct;1210:66-77
pubmed: 20973800
Clin Chem. 2011 Mar;57(3):421-30
pubmed: 21245367
J Cell Biol. 2011 Feb 7;192(3):373-82
pubmed: 21300848
Clin Chem. 2011 Sep;57(9):1242-55
pubmed: 21784769
Int J Oncol. 2012 Oct;41(4):1241-50
pubmed: 22825490
Urology. 2012 Dec;80(6):1328-32
pubmed: 23063057
Sci Transl Med. 2013 Jan 23;5(169):169ra10
pubmed: 23345608
J Cancer Res Clin Oncol. 2013 May;139(5):755-63
pubmed: 23358719
J Endourol. 2013 Aug;27(8):1061-7
pubmed: 23641793
Prostate Cancer Prostatic Dis. 2014 Mar;17(1):57-63
pubmed: 24189998
J Clin Oncol. 2014 Apr 10;32(11):1136-42
pubmed: 24616308
J Natl Cancer Inst. 2014 May 15;106(5):null
pubmed: 24832787
Eur Urol. 2014 Sep;66(3):550-60
pubmed: 24836057
Curr Urol. 2013 Nov;7(2):65-9
pubmed: 24917761
Anticancer Res. 2014 Jul;34(7):3641-6
pubmed: 24982381
J Cancer Res Clin Oncol. 2014 Dec;140(12):2157-62
pubmed: 25028119
Cell Rep. 2014 Aug 7;8(3):798-806
pubmed: 25066126
Nat Rev Cancer. 2014 Sep;14(9):623-31
pubmed: 25154812
Cell. 2014 Aug 28;158(5):1110-1122
pubmed: 25171411
N Engl J Med. 2014 Sep 11;371(11):1028-38
pubmed: 25184630
Urol Oncol. 2015 Mar;33(3):110.e1-9
pubmed: 25595577
Nat Methods. 2015 Jul;12(7):685-91
pubmed: 25984697
Nat Genet. 2015 Jul;47(7):736-45
pubmed: 26005866
Prostate Cancer Prostatic Dis. 2015 Dec;18(4):358-64
pubmed: 26238233
Sci Transl Med. 2015 Aug 26;7(302):302ra133
pubmed: 26311728
Anticancer Res. 2015 Oct;35(10):5679-85
pubmed: 26408743
Clin Cancer Res. 2016 May 1;22(9):2197-206
pubmed: 26667488
Mol Oncol. 2016 Mar;10(3):374-94
pubmed: 26897752
Proc Natl Acad Sci U S A. 2016 May 3;113(18):4947-52
pubmed: 27091969
PLoS One. 2016 May 16;11(5):e0155126
pubmed: 27182774
JAMA Oncol. 2016 Nov 1;2(11):1441-1449
pubmed: 27262168
Sci Transl Med. 2016 Jul 6;8(346):346ra92
pubmed: 27384348
Sci Rep. 2016 Dec 21;6:39736
pubmed: 28000772
Sci Rep. 2017 Feb 24;7:43424
pubmed: 28233867
J Clin Oncol. 2017 Jul 1;35(19):2149-2156
pubmed: 28384066
Sci Rep. 2017 May 26;7(1):2433
pubmed: 28550299
Mol Cell Endocrinol. 2018 Feb 15;462(Pt A):56-63
pubmed: 28882555
Adv Clin Chem. 2017;82:71-103
pubmed: 28939214
Clin Chem. 2018 Feb;64(2):297-306
pubmed: 29122836
Clin Chem. 2018 Mar;64(3):536-546
pubmed: 29301749
Oncotarget. 2018 Apr 10;9(27):19283-19293
pubmed: 29721202
J Vis Exp. 2018 May 15;(135):
pubmed: 29863657
Clin Cancer Res. 2018 Nov 15;24(22):5635-5644
pubmed: 30093450
Lancet. 2018 Dec 1;392(10162):2353-2366
pubmed: 30355464
Eur Urol. 2019 Mar;75(3):535-536
pubmed: 30466892
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Cell. 2019 Jan 10;176(1-2):98-112.e14
pubmed: 30633912
Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):33-35
pubmed: 30967237
J Urol. 1995 Aug;154(2 Pt 1):407-13
pubmed: 7541857
Science. 1997 Mar 28;275(5308):1943-7
pubmed: 9072974
JAMA. 1998 Sep 16;280(11):969-74
pubmed: 9749478